Online Inquiry

Eukaryotic/Prokaryotic Native tRNA Purification

At GCEngine, native tRNAs serve as essential biological benchmarks for comparison with engineered and orthogonal tRNA variants. Their post-transcriptional modifications, structural conformations, and folding patterns reflect the natural state of the translation apparatus in living systems. Our eukaryotic and prokaryotic native tRNA purification service enriches intact, full-length tRNAs from microbial or eukaryotic cells with high recovery and preserved integrity.

Introduction to Eukaryotic / Prokaryotic Native tRNA Purification

tRNAs exist as a diverse family of molecules—each heavily modified and intricately folded to perform precise decoding during translation. Their extraction from biological cells presents unique challenges:

  • Co-purification with rRNA/mRNA due to similar size and charge.
  • Loss of modifications during harsh chemical extraction.
  • Contamination by degraded RNA fragments or genomic DNA.

For the GCEngine platform, maintaining modification fidelity and structural integrity during purification is crucial. Native tRNAs derived from prokaryotic hosts (e.g., E. coli, Bacillus subtilis) or eukaryotic systems (e.g., yeast, CHO, or HEK cells) provide essential reference material for understanding natural modification hierarchies, enzymatic adaptation, and codon decoding mechanisms—all of which guide rational design of orthogonal tRNA systems.

Our Services

Our eukaryotic and prokaryotic native tRNA purification service provides a complete workflow for isolating total or specific native tRNAs from diverse biological sources. Each purification scheme is designed to maintain modification patterns and tertiary folding while removing contaminants such as rRNA, mRNA, DNA, and proteins. The process integrates cell lysis, phase extraction, chromatographic enrichment, and optional affinity- or gel-based refinement to produce native tRNA suitable for structural, biochemical, and translational studies within the GCEngine framework.

Cell Lysis and RNA Extraction

The GCEngine process begins with gentle mechanical or enzymatic lysis tailored to the organism type. For prokaryotic cells, enzymatic digestion (lysozyme-based) and phenol-free extraction maximize recovery of intact tRNA species. For eukaryotic cells, detergent-assisted lysis with nuclease inhibitors preserves endogenous modification states. All workflows are designed to avoid oxidative or hydrolytic stress that could alter tRNA chemistry.

Phase Separation and Total RNA Enrichment

Following lysis, total RNA is separated via optimized phenol/chloroform or column-based extraction. The protocol removes protein contaminants while retaining the small RNA fraction. Each preparation undergoes ethanol precipitation and desalting under cold, RNase-free conditions to preserve modification fidelity. At this stage, total RNA typically contains ~10–15% tRNA by weight.

tRNA Fractionation and Enrichment

Native tRNA enrichment utilizes size- and charge-based methods, including anion-exchange chromatography, LiCl precipitation, or gel filtration. For scalable purification, DEAE– or Q–Sepharose columns can achieve around 90% tRNA purity in our internal benchmarks while preserving modification integrity. This process yields a pooled, native tRNA repertoire; individual isoacceptors (e.g., tRNAArg vs. tRNAAla) are not separated. Specific tRNA species can be further isolated upon request (see below).

Post-Purification Validation

Purified native tRNAs are analyzed by denaturing PAGE, UV–Vis spectrophotometry, and LC–MS/MS for modification profiling. The GCEngine QC process evaluates molecular integrity, base composition, and purity, verifying that each purified fraction displays modification signatures (e.g., Ψ55, m¹A58, m⁵C38, s²U34) consistent with native tRNAs from the corresponding organism. These data support the use of purified tRNAs as biologically authentic references for comparative or functional studies.

Isoacceptor-Specific Purification

To isolate a specific tRNA isoacceptor (e.g., tRNAArg or tRNAAla) from the enriched native tRNA pool, sequence- or function-specific steps are required. We offer the following advanced purification modules:

Oligonucleotide Affinity Capture

This method utilizes biotinylated antisense DNA or LNA/DNA mixmers designed to target the anticodon loop or other identity elements of the desired tRNA. The oligonucleotide is immobilized on streptavidin beads or columns to capture the specific tRNA from the native pool, followed by precise elution. This approach is robust and scalable, suitable for obtaining individual native tRNA species.

Functional Affinity Purification (Research-Grade)

For applications requiring functionally charged tRNAs, affinity matrices coupled with specific aminoacyl-tRNA synthetases (aaRS) or EF-Tu can be employed. This method enriches tRNAs based on their aminoacylation state and interaction with translation factors, though conditions are more stringent.

For detailed protocols and service options on high-resolution tRNA isolation, please refer to our Oligonucleotide- and Affinity-Tag tRNA Isolation service.

Contact Us

Native tRNAs are a blueprint of translational accuracy. The GCEngine platform combines biochemical precision with analytical depth to isolate natural tRNAs from both prokaryotic and eukaryotic sources—using workflows designed to preserve their structure, modifications, and function for advanced genetic code expansion research. Contact us today to request native tRNA purification and build a reliable reference foundation for your orthogonal translation and ncAA incorporation studies.

All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.

Rare Skin Diseases

A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.

USA

Denmark